TransAlgae logo — Breakthrough microalgae platform for the oral delivery of hi...

TransAlgae

Breakthrough microalgae platform for the oral delivery of high value molecules

Founded 2023 Israel Israel 13 employees Angel Total: $2.50M Biotechnology, Clean Energy

General Information

Company Name TransAlgae
Founded Year 2023
Location Israel Israel
Employees 13
Industries Biotechnology, Clean Energy
Funding Stage Angel
Social

BounceWatch is an independent company data service, not affiliated with TransAlgae. To contact TransAlgae, visit transalgae.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does TransAlgae compare?

A PDF of TransAlgae and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting TransAlgae soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About TransAlgae

TransAlgae is an Israeli startup that has been making waves with its breakthrough microalgae platform for the oral delivery of high-value molecules. Founded in 2010, the company operates in the biotechnology and clean energy sectors. Their innovative microalgae-based oral delivery platform has garnered attention, leading to a recent $2.50M Angel Round investment on 09 April 2021. This investment came from the Gan Shmuel Group, showcasing the interest and confidence of investors in the potential of TransAlgae's technology. With a focus on leveraging microalgae for effective oral delivery, TransAlgae positions itself at the forefront of biotech innovation, addressing critical needs in the pharmaceutical and nutraceutical industries.

Business keywords: animal health, vaccines, crop protection, gene editing, RNAi, pharma, insecticides, algae, proteins, aquaculture

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Round $2.50M 1
Gan Shmuel Group
09 Apr 2021

TransAlgae Alternatives & Competitors

View All Alternatives
TransAlgae vs
AlgiSys
AlgiSys United Kingdom

EPA OMEGA-3 and PLANT PROTEIN Directly From MICROALGAE. Eco-Friendly ● Sustainable ● Cost Effective...

Series B
8 employees
Biotechnology, Pharmaceutical
TransAlgae vs
Helex
Helex United States

Genomic medicines for kidney diseases with high unmet need

Seed
33 employees
Biotechnology, Clean Energy
TransAlgae vs
DNAnexus
DNAnexus United States

The World’s Most Trusted Platform for Precision Health

274 employees
Biotechnology, Computing

FAQ About TransAlgae

Breakthrough microalgae platform for the oral delivery of high value molecules
TransAlgae was founded in 2023.
TransAlgae is headquartered in Israel.
TransAlgae operates in Biotechnology and Clean Energy. Its work centres on animal health, vaccines, crop protection and gene editing.
TransAlgae has approximately 13 employees.
TransAlgae has completed 1 funding round, raising a total of $2.50M. The latest funding stage is Angel.
Top alternatives and competitors to TransAlgae include AlgiSys, Helex, DNAnexus, Mission Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TransAlgae and AlgiSys are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for TransAlgae, https://bouncewatch.com/company/transalgae, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes